Why is St. Jude unique for treatment of leukemia and lymphoma?

  • St. Jude is the first and only National Cancer Institute-designated Comprehensive Cancer Center devoted solely to children.
  • The most advanced medical technology is available at St. Jude. The hospital offers the latest in treatment modalities, providing cost-efficient and effective therapies.
  • St. Jude develops more clinical trials for cancer than any other children’s hospital in the United States.
  • The nurse-to-patient ratio at St. Jude is unmatched — averaging 1:3 in hematology and oncology, and 1:1 in the Intensive Care Unit.
  • St. Jude patients with acute lymphoblastic leukemia have a 94 percent survival rate, the best worldwide outcomes for that disease.
  • St. Jude was the first hospital in the U.S. to remove cranial irradiation from treatment for ALL while maintaining excellent survival rates.
  • St. Jude pioneered outpatient treatment protocols for children with catastrophic diseases, reducing the need for inpatient stays.
  • St. Jude has built an exceptional medical staff. Experts in hematology, oncology and infectious diseases, as well as other specialists, are available for consultation.
  • Patients at St. Jude are followed throughout the treatment process and are typically managed in close collaboration with their private physicians.
  • Children and families confronted with a catastrophic disease benefit from the psychological, spiritual, developmental and social support they receive from the physicians, employees and other families at St. Jude.
  • Educational assistance is offered to out-of-town patients who are in Memphis for an extended period of time. Two certified Memphis schoolteachers coordinate activities with the child’s school, enabling children to fit easily back into the school environment once they return home.